Naperville, IL -- (SBWIRE) -- 06/19/2014 -- Reportstack, provider of premium market research reports announces the addition of Cancer Cell Therapy Market and Pipeline Insight market report to its offering
Since the past 3-5 years, a more complex therapeutic modality has been is emerging as cell therapies which have been developed to treat diseases which are not amenable to treatment with more classical pharmaceutical or biopharmaceutical products. This market offers the promise of successfully regenerating damaged tissues and organs in the body by replacing the damaged tissue and/or by stimulating the body’s own repair mechanisms to heal previously irreparable tissues. With their rising popularity, these therapies are becoming more cost effective and efficient.
The discovery of cell therapies has changed the notion that cancer was otherwise incurable. With the efficient capability of cell-based therapies, the number of patients being treated successfully of cancer and similar diseases has increased significantly in recent years, thus leading to the increasing popularity of cell therapy across the globe. Cell therapy for cancer treatment thus represents a paradigm shift in healthcare therapies and treatment by focusing on the basic reason of the occurrence of the disease by repairing, replacing or regenerating damaged cells of the body.
With the cell-based therapies growing significantly, it is expected that the future years would witness significant advancements in technology in the cell therapy market. Increasing incidence of cancer along with lack of adequate effective treatment is most likely to drive the cancer cell therapy technology in developed and developing nations. Among the emerging trends of the global market, the most prominent one is the development of sophisticated automation devices for cell expansion and culture process which could be used in the treatment of cancer and other life threatening diseases.
Additionally, cell based therapies, in the next 3-4 year horizon would be increasingly used to have a better and deeper understanding of the working of genetics in the early stages of cell development. This would in turn enable scientists to understand the reasons of abnormal development of cancer cells. Thus, with the complete knowledge of genetic basis for cell development, scientists would be in a better position to develop efficient drugs and prevent the spread of cancer.
“Cancer Cell Therapy Market & Pipeline Insight” Report Highlights & Findings:
Cancer Cell Therapy Market Overview
Cancer Cell Therapy Market Dynamics
Clinical Pipeline by Phase, country & Target Indications
Cancer Cell Therapy Drugs in Pipeline: 82
Highest Number of Drugs in Preclinical Stage:29
Suspended & Discontinued Drug Profiles
Adaptimmune,Apceth,Argos Therapeutics Inc,Celgene Cellular Therapeutics,Cellerant Therapeutics,Immunicum, Innate Pharma, Innocell Corporation, Kite Pharma, Takara Bio
To view the table of contents for this market research report please visit